AON
63
-2
CVS
41
-2
CHD
32
-3
BAX
38
-3
CINF
58
-2
AEP
64
-3
ADT
48
2
DD
34
-4
AAP
5
-3
CME
49
-4
AVGO
40
-5
AN
47
-2
CHRW
71
-2
EQT
50
-3
VIX
49
6
BDX
57
-2
AVY
47
-4
AMG
75
-4
EMR
60
-7
DOV
63
-6
AON
63
-2
CVS
41
-2
CHD
32
-3
BAX
38
-3
CINF
58
-2
AEP
64
-3
ADT
48
2
DD
34
-4
AAP
5
-3
CME
49
-4
AVGO
40
-5
AN
47
-2
CHRW
71
-2
EQT
50
-3
VIX
49
6
BDX
57
-2
AVY
47
-4
AMG
75
-4
EMR
60
-7
DOV
63
-6
Financhill
Back

First Trust S&P 500 Diversified Free Cash Flow ETF Vs. Corcept Therapeutics, Inc. Industry Stock Comparison

Sell
42

FCFY
First Trust S&P 500 Diversified Free Cash Flow ETF

Last Price:
$28.04
Seasonality Move:
-0.17%
Sell
30

CORT
Corcept Therapeutics, Inc.

Last Price:
$34.79
Seasonality Move:
13.21%
Sell
42
First Trust S&P 500 Diversified Free Cash Flow ETF (FCFY) is a Sell

Is First Trust S&P 500 Diversified Free Cash Flow ETF a Buy, Sell or Hold?

  • The current First Trust S&P 500 Diversified Free Cash Flow ETF [FCFY] share price is $27.66. The Score for FCFY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • FCFY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCFY Stock Price Chart

What is First Trust S&P 500 Diversified Free Cash Flow ETF's stock price today?

CORT Stock Price Chart

What is Corcept Therapeutics, Inc.'s stock price today?

  • The Corcept Therapeutics, Inc. share price today is $34.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.

FCFY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 52.78 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.02 - 28.08) Buy
Bollinger Bands (100): (26.18 - 27.48) Buy

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.88 Sell
Relative Strength Index (14 RSI): 14.83 Sell
Chaikin Money Flow: -8077532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.63 - 90.59) Sell
Bollinger Bands (100): (69.66 - 84.14) Sell

FCFY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.91 Sell
20-day SMA: 27.77 Sell
50-day SMA: 27.05 Buy
200-day SMA: 25.32 Buy
8-day EMA: 27.86 Sell
20-day EMA: 27.66 Buy
50-day EMA: 27.21 Buy
200-day EMA: 25.88 Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.24 Sell
20-day SMA: 80.76 Sell
50-day SMA: 77.62 Sell
200-day SMA: 73.92 Sell
8-day EMA: 69.79 Sell
20-day EMA: 76.79 Sell
50-day EMA: 77.19 Sell
200-day EMA: 51.2 Sell

First Trust S&P 500 Diversified Free Cash Flow ETF Earnings Growth & FCFY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.

First Trust S&P 500 Diversified Free Cash Flow ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):